Skip to Content
Biotechnology and health

Russia wants you to hate GMOs

February 28, 2018

Misinformation attacks like those aimed at the US presidential race may be scaring people about genetic modification.

The news: Researchers from Iowa State University found that RT and Sputnik, two state-funded Russian news sites, were full of GMO-related articles—as many as Huffington Post, Fox News, CNN, Breitbart News, and MSNBC combined.

Throwing biotech shade: Most of the articles included “negative or distasteful” information about GMOs, according to the Des Moines Register. Others peddled fake conspiracy theories. One read: “GMO mosquitoes could be the cause of Zika outbreak, critics say.” 

Backstory: Russia has banned GMOs. According to RT (so consume with salt), Russia wants to be the leading exporter of organic food.

Seeds of doubt: GMOs are already divisive. To the Iowa State team, the work is proof that Russia is targeting fake news at the topic. But as Gizmodo notes, American anti-GMO outfits says the scientists are using research to silence credible media concerns. Don’t know who to believe? That’s kinda the point.

Deep Dive

Biotechnology and health

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

The quest to legitimize longevity medicine

Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.

There is a new most expensive drug in the world. Price tag: $4.25 million

But will the latest gene therapy suffer the curse of the costliest drug?

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.